- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer radioimmunotherapy
Authors
Keywords
-
Journal
Immunotherapy
Volume 3, Issue 3, Pages 349-370
Publisher
Future Medicine Ltd
Online
2011-03-11
DOI
10.2217/imt.10.114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improved18F Labeling of Peptides with a Fluoride-Aluminum-Chelate Complex
- (2010) William J. McBride et al. BIOCONJUGATE CHEMISTRY
- Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced- intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: results of a phase 2 study
- (2010) W. A. Bethge et al. BLOOD
- Anti-prostate-Specific membrane antigen-based radioimmunotherapy for prostate cancer
- (2010) Scott T. Tagawa et al. CANCER
- Phase I single-dose study of intracavitary-administered Nimotuzumab labeled with 188-Re in adult recurrent high-grade glioma
- (2010) Angel Casaco et al. CANCER BIOLOGY & THERAPY
- A Pretherapy Biodistribution and Dosimetry Study of Indium-111-Radiolabeled Trastuzumab in Patients with Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer
- (2010) Jeffrey Y.C. Wong et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Phase II Trial of Short-Course R-Chop Followed by 90Y-Ibritumomab Tiuxetan in Previously Untreated High-Risk Elderly Diffuse Large B-Cell Lymphoma Patients
- (2010) P. L. Zinzani et al. CLINICAL CANCER RESEARCH
- Lack of Correlation between Epidermal Growth Factor Receptor Status and Response to Panitumumab Monotherapy in Metastatic Colorectal Cancer
- (2010) J. R. Hecht et al. CLINICAL CANCER RESEARCH
- Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell Carcinoma
- (2010) G. Niu et al. CLINICAL CANCER RESEARCH
- Cyclophosphamide, Vincristine, and Prednisone Followed by Tositumomab and Iodine-131–Tositumomab in Patients With Untreated Low-Grade Follicular Lymphoma: Eight-Year Follow-Up of a Multicenter Phase II Study
- (2010) Brian K. Link et al. JOURNAL OF CLINICAL ONCOLOGY
- High Rates of Durable Responses With Anti-CD22 Fractionated Radioimmunotherapy: Results of a Multicenter, Phase I/II Study in Non-Hodgkin's Lymphoma
- (2010) Franck Morschhauser et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Trastuzumab-DM1, an HER2 Antibody-Drug Conjugate, Given Every 3 Weeks to Patients With HER2-Positive Metastatic Breast Cancer
- (2010) Ian E. Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- Radioimmunotherapy Is More Effective than Antifungal Treatment in Experimental Cryptococcal Infection
- (2010) Ruth A. Bryan et al. JOURNAL OF INFECTIOUS DISEASES
- A Phase II study of anti–epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme
- (2010) Linna Li et al. JOURNAL OF NEUROSURGERY
- 131I-Tositumomab Radioimmunotherapy: Initial Tumor Dose-Response Results Using 3-Dimensional Dosimetry Including Radiobiologic Modeling
- (2010) Y. K. Dewaraja et al. JOURNAL OF NUCLEAR MEDICINE
- Comparative Toxicity and Efficacy of Combined Radioimmunotherapy and Antiangiogenic Therapy in Carcinoembryonic Antigen-Expressing Medullary Thyroid Cancer Xenograft
- (2010) F. Kraeber-Bodere et al. JOURNAL OF NUCLEAR MEDICINE
- Pretargeted 177Lu Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colonic Tumors in Mice
- (2010) R. Schoffelen et al. JOURNAL OF NUCLEAR MEDICINE
- Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention
- (2010) E. Vegt et al. JOURNAL OF NUCLEAR MEDICINE
- Targeting HER2
- (2010) Diane E. Milenic et al. mAbs
- Antibodies to watch in 2010
- (2010) Janice M. Reichert mAbs
- Solid-tumor radionuclide therapy dosimetry: New paradigms in view of tumor microenvironment and angiogenesis
- (2010) Xuping Zhu et al. MEDICAL PHYSICS
- Pretargeted Immuno–Positron Emission Tomography Imaging of Carcinoembryonic Antigen–Expressing Tumors with a Bispecific Antibody and a68Ga- and18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts
- (2010) Rafke Schoffelen et al. MOLECULAR CANCER THERAPEUTICS
- Epidermal Growth Factor Receptor–Targeted Radioimmunotherapy of Human Head and Neck Cancer Xenografts Using90Y-Labeled Fully Human Antibody Panitumumab
- (2010) Zhaofei Liu et al. MOLECULAR CANCER THERAPEUTICS
- Development trends for human monoclonal antibody therapeutics
- (2010) Aaron L. Nelson et al. NATURE REVIEWS DRUG DISCOVERY
- Antibody Vectors for Imaging
- (2010) Tove Olafsen et al. SEMINARS IN NUCLEAR MEDICINE
- Recombinant Bispecific Monoclonal Antibodies Prepared by the Dock-and-Lock Strategy for Pretargeted Radioimmunotherapy
- (2010) Robert M. Sharkey et al. SEMINARS IN NUCLEAR MEDICINE
- Kinetics of Vascular Targeted Monoclonal Antibody
- (2010) Stephen J. Kennel et al. Current Drug Delivery
- Radioimmunotherapy Is Effective against High-Inoculum Cryptococcus neoformans Infection in Mice and Does Not Select for Radiation-Resistant Cryptococcal Cells
- (2009) R. A. Bryan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Radiolabeled Antibodies to Bacillus anthracis Toxins Are Bactericidal and Partially Therapeutic in Experimental Murine Anthrax
- (2009) J. Rivera et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations
- (2009) J. M. Pagel et al. BLOOD
- A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapy
- (2009) R. M. Sharkey et al. BLOOD
- Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates
- (2009) D. J. Green et al. BLOOD
- Affinity and Avidity in Antibody-Based Tumor Targeting
- (2009) Stephen I. Rudnick et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Radioimmunotherapy of Breast Cancer Metastases with -Particle Emitter 225Ac: Comparing Efficacy with 213Bi and 90Y
- (2009) H. Song et al. CANCER RESEARCH
- A Phase I Trial of Radioimmunotherapy with 131I-A5B7 Anti-CEA Antibody in Combination with Combretastatin-A4-Phosphate in Advanced Gastrointestinal Carcinomas
- (2009) T. Meyer et al. CLINICAL CANCER RESEARCH
- Radioactive EGFR Antibody Cetuximab in Multimodal Cancer Treatment: Stability and Synergistic Effects With Radiotherapy
- (2009) Dirk Rades et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Yttrium-90-ibritumomab tiuxetan in combination with intravenous busulfan, cyclophosphamide, and etoposide followed by autologous stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma
- (2009) Byung Woog Kang et al. INVESTIGATIONAL NEW DRUGS
- Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
- (2009) Kim Kramer et al. JOURNAL OF NEURO-ONCOLOGY
- Pretargeted Versus Directly Targeted Radioimmunotherapy Combined with Anti-CD20 Antibody Consolidation Therapy of Non-Hodgkin Lymphoma
- (2009) R. M. Sharkey et al. JOURNAL OF NUCLEAR MEDICINE
- Intraperitoneal -Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of 211At-MX35 F(ab')2--A Phase I Study
- (2009) H. Andersson et al. JOURNAL OF NUCLEAR MEDICINE
- Pretargeted Radioimmunotherapy of Pancreatic Cancer Xenografts: TF10-90Y-IMP-288 Alone and Combined with Gemcitabine
- (2009) H. Karacay et al. JOURNAL OF NUCLEAR MEDICINE
- Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of α-particle-emitting 211At-labeled trastuzumab
- (2009) Abraham Boskovitz et al. NUCLEAR MEDICINE AND BIOLOGY
- Radioimmunotherapy for Stem Cell Transplantation in Non-Hodgkin's Lymphoma: In Pursuit of a Complete Response
- (2009) C. Gisselbrecht et al. ONCOLOGIST
- Rationale for Consolidation to Improve Progression-Free Survival in Patients with Non-Hodgkin's Lymphoma: A Review of the Evidence
- (2009) F. Morschhauser et al. ONCOLOGIST
- Chemotherapy Synergizes with Radioimmunotherapy Targeting La Autoantigen in Tumors
- (2009) Fares Al-Ejeh et al. PLoS One
- Radioimmunotherapy of Infectious Diseases
- (2009) Ekaterina Dadachova et al. SEMINARS IN NUCLEAR MEDICINE
- Radioimmunotherapy: Strategies for the future in indolent and aggressive lymphoma
- (2009) Waleed Alduaij et al. Current Oncology Reports
- Use of antibodies and immunoconjugates for the therapy of more accessible cancers
- (2008) Robert M. Sharkey et al. ADVANCED DRUG DELIVERY REVIEWS
- Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications
- (2008) Matthias Miederer et al. ADVANCED DRUG DELIVERY REVIEWS
- Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy
- (2008) T. M. Illidge et al. BLOOD
- Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab
- (2008) A. K. Gopal et al. BLOOD
- A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma
- (2008) Pier Luigi Zinzani et al. CANCER
- Review: Intracavitary Radioimmunotherapy to Treat Solid Tumors
- (2008) Frits Aarts et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Cetuximab: Preclinical Evaluation of a Monoclonal Antibody Targeting EGFR for Radioimmunodiagnostic and Radioimmunotherapeutic Applications
- (2008) Diane E. Milenic et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Improved Therapeutic Results by Pretargeted Radioimmunotherapy of Non-Hodgkin's Lymphoma with a New Recombinant, Trivalent, Anti-CD20, Bispecific Antibody
- (2008) R. M. Sharkey et al. CANCER RESEARCH
- Phase II Trial of Short-Course CHOP-R Followed by 90Y-ibritumomab Tiuxetan and Extended Rituximab in Previously Untreated Follicular Lymphoma
- (2008) S. A. Jacobs et al. CLINICAL CANCER RESEARCH
- Radiation Therapy with Tositumomab (B1) Anti-CD20 Monoclonal Antibody Initiates Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase-Dependent Cell Death that Overcomes Resistance to Apoptosis
- (2008) A. Ivanov et al. CLINICAL CANCER RESEARCH
- Therapy of Advanced B-Lymphoma Xenografts with a Combination of 90Y-anti-CD22 IgG (Epratuzumab) and Unlabeled Anti-CD20 IgG (Veltuzumab)
- (2008) M. J. Mattes et al. CLINICAL CANCER RESEARCH
- Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electrons
- (2008) M. Jules Mattes et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The mechanism of killing of B-lymphoma cells by111In-conjugated antibodies
- (2008) M. Jules Mattes INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma
- (2008) Franck Morschhauser et al. JOURNAL OF CLINICAL ONCOLOGY
- High-Dose Yttrium-90–Ibritumomab Tiuxetan With Tandem Stem-Cell Reinfusion: An Outpatient Preparative Regimen for Autologous Hematopoietic Cell Transplantation
- (2008) Liliana Devizzi et al. JOURNAL OF CLINICAL ONCOLOGY
- In Vitro Evaluation of Radioprotective and Radiosensitizing Effects of Rituximab
- (2008) N. S. Kapadia et al. JOURNAL OF NUCLEAR MEDICINE
- Trastuzumab-Resistant Breast Cancer Cells Remain Sensitive to the Auger Electron-Emitting Radiotherapeutic Agent 111In-NLS-Trastuzumab and Are Radiosensitized by Methotrexate
- (2008) D. L. Costantini et al. JOURNAL OF NUCLEAR MEDICINE
- Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ)
- (2008) Pier Luigi Zinzani et al. LANCET ONCOLOGY
- Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology
- (2008) B. M. Tijink et al. MOLECULAR CANCER THERAPEUTICS
- A pilot study: 131I-Antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost
- (2008) David A. Reardon et al. NEURO-ONCOLOGY
- First report on a prospective trial with yttrium-90–labeled ibritumomab tiuxetan (Zevalin) in primary CNS lymphoma
- (2008) Sofiane Maza et al. NEURO-ONCOLOGY
- Therapeutic efficacy of177Lu-CHX-A″-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy
- (2008) Marcus P. Kelly et al. PROSTATE
- Metastatic Human Colonic Carcinoma: Molecular Imaging with Pretargeted SPECT and PET in a Mouse Model
- (2008) Robert M. Sharkey et al. RADIOLOGY
- Radioimmunotherapy-Based Conditioning Regimens for Stem Cell Transplantation
- (2008) Michelle M. Zhang et al. SEMINARS IN HEMATOLOGY
- Therapeutic Radionuclides: Biophysical and Radiobiologic Principles
- (2008) Amin I. Kassis SEMINARS IN NUCLEAR MEDICINE
- Phase II Trial of a Transplantation Regimen of Yttrium-90 Ibritumomab Tiuxetan and High-Dose Chemotherapy in Patients With Non-Hodgkin's Lymphoma
- (2007) Amrita Krishnan et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started